Roche Diagnostics Operations, Inc. is recalling approximately 5,263 Tina-quant D-Dimer Test System kits because they may produce incorrectly high (elevated) results when using Li-heparin plasma samples compared to standard citrated plasma samples. This recall affects the test systems used on several analyzer models, including the cobas c 311, 501, 502, 503, 303, and INTEGRA 400 plus. Consumers and healthcare providers should be aware that inaccurate test results could lead to improper medical assessments.
Incorrectly elevated D-dimer results can lead to false-positive findings, potentially resulting in unnecessary medical procedures, misdiagnosis of blood clotting disorders, or inappropriate treatment plans for patients.
Manufacturer consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.